Status:
COMPLETED
Fatty Liver and Obstructive Sleep Apnea
Lead Sponsor:
Assaf-Harofeh Medical Center
Conditions:
Non-Alcoholic Fatty Liver Disease
Obstructive Sleep Apnea
Eligibility:
All Genders
30-60 years
Phase:
NA
Brief Summary
Non-alcoholic fatty liver disease is associated with obstructive sleep apnea. Abnormalities in liver enzymes can improve following continuous positive airway pressure in patients with obstructive slee...
Eligibility Criteria
Inclusion
- Obstructive sleep apnea, defined as AHI\>5/h
Exclusion
- Consumption of more than 20 grams of alcohol per 24 h
- Known autoimmune disease
- Usage of known hepatotoxic drugs
- Medical history positive for viral hepatitis or other chronic liver disease
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00730873
Last Update
August 8 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The pulmonary institute, Asaf Harofeh Medical Center
Ẕerifin, Israel, 70300